- €1.39bn
- €1.42bn
- €493.65m
- 65
- 48
- 66
- 65
Annual balance sheet for Faes Farma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 93.1 | 73.4 | 84.1 | 47.8 | 72.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 105 | 112 | 114 | 114 | 118 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 290 | 294 | 313 | 290 | 334 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 95.2 | 140 | 206 | 281 | 301 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 582 | 645 | 726 | 777 | 853 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 84.7 | 79.3 | 94.4 | 87.3 | 103 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 110 | 109 | 125 | 114 | 127 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 471 | 536 | 601 | 662 | 726 |
| Total Liabilities & Shareholders' Equity | 582 | 645 | 726 | 777 | 853 |
| Total Common Shares Outstanding |